Consumer Reports has a look at the eyelash-enhancing product

In its ninth installment, Consumer Reports AdWatch takes a look at the eyelash growing drug Latisse. The ad is everywhere.

And while it may be easy to spot a TV commercial for Latisse, it’s not so easy for consumers to recognize the downside of gorgeous eyelashes.

Consumer Reports spells it out—the drug, which costs about $100 a month, could make hair grow in places you don’t want it; it could turn your blue eyes brown; it could cause darkening of the lower eyelids and a “raccoon” look; and it could give you itchy, red eyes. And P.S., when you stop using Latisse, your eyelashes return to normal.

Consumer Reports notes that Latisse has caught the eye of the Food and Drug Administration, which in September warned Allergan that promotional materials on the drug’s Web site omitted or minimized certain risks.

As noted in a blog posted at ConsumerReportsHealth.org, the Latisse commercial embodies pretty much everything that’s wrong with direct-to-consumer advertising.

Click here for the blog and the Ad Watch video


Related Articles

This entry was posted on Thursday, November 19th, 2009 at 7:49 am and is filed under Makeup. You can follow any comments to this entry through the RSS 2.0 feed. You can leave a comment.


One comment for “Latisse May Not Be All It’s Made Up To Be”

  1. alexmakeupgirl Says:

    Wow!! I didn’t realize there were so many nasty side effects associated with Latisse. I don’t use it, but do use an eyelash growth serum called Revitalash. This stuff works! Didn’t suffer any of the side effects mentioned above. I highly recommend Revitalash as an alternative to Latisse. Only took 8-9 weeks to see a noticable difference. Has anyone out there tried Latisse?